EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model

Taein Lee, Hye-Sun Lee, Sangjun Yoo, Hoyoung Bae, Min Chul Cho iD, Junghoon Lee, Hyeon Jeong

Cells · 2025

DOI: 10.3390/cells14241981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Taein Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of …. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Receptor, EphA2, Disease Progression. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University Hospital, Seoul National University Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We investigated whether EphA2 inhibition can attenuate the progression of renal cell carcinoma (RCC) in an orthotopic mouse model of kidney tumor cells (Renca). Materials and Methods: 16 BALB/c mice were divided into two groups and implanted with either control or shRNA-mediated, EphA2-knockdown Renca–Luciferase cells via injection under the right renal capsule. Tumor progression was followed by in vivo bioluminescence imaging (BLI). Tumor growth was evaluated via ex vivo BLI and the wet weight of harvested orthotopic kidneys on day 18. Tumor apoptosis was evaluated using the TUNEL assay. Changes in FAK/RhoA signaling, a mediator of malignant cellular behavior, were determined using Western blotting and RT-PCR.

Results

The TUNEL assay showed increased apoptosis of tumor cells in the EphA2-knockdown group compared to that in the control group (p = 0.021). Tumor wet weight (1569.9 ± 595.5 vs. 636.5 ± 288.9 mg, p = 0.009) and activation of RhoA and FAK were decreased in the EphA2-knockdown group (p < 0.05 for all). Tumor burden was reduced in the EphA2-knockdown group according to in vivo BLI on days 14 and 18 and an ex vivo test (p = 0.021, p = 0.043, p = 0.021).

Conclusions

EphA2 knockdown significantly reduced the progression of RCC by inducing tumor apoptosis and suppressing FAK/RhoA signaling in an orthotopic mouse model. The EphA2/FAK/RhoA pathway might constitute a potential target to suppress the progression of RCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsReceptor, EphA2Disease ProgressionGene SilencingAnimalsApoptosisCell Line, TumorMiceMice, Inbred BALB CDisease Models, AnimalrhoA GTP-Binding ProteinSignal TransductionHumansCell ProliferationFocal Adhesion Kinase 1

Stichwörter der Autor:innen

EphA2Rencabioluminescence imagingorthotopic mouserenal cell carcinoma

Substanzen

Receptor, EphA2rhoA GTP-Binding ProteinFocal Adhesion Kinase 1EPHA2 protein, human

Autor:innen und Institutionen

  • Department of Urology, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul 07061, Republic of Korea.
  • Department of Urology, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Min Chul Cho

Förderung

  • Seoul National University Hospital
  • Seoul National University Hospital Research Fund

Zitieren

APA

Lee, T., Lee, H. S., Yoo, S., Bae, H., Cho, M. C., Lee, J., & Jeong, H. (2025). Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model. Cells. https://doi.org/10.3390/cells14241981

Vancouver

Lee T, Lee HS, Yoo S, Bae H, Cho MC, Lee J, et al. Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model. Cells. 2025. doi:10.3390/cells14241981

BibTeX
@article{Lee2025,
  author = {Lee, Taein and Lee, Hye-Sun and Yoo, Sangjun and Bae, Hoyoung and Cho, Min Chul and Lee, Junghoon and Jeong, Hyeon},
  title = {Effect of EphA2 Silencing on Inhibiting the Progression of Renal Cell Carcinoma in an Orthotopic Mouse Model},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14241981}
}
Kostenlos starten →